Plasma extracts
About This Opportunity
healthcare supply contract awarded in France: Médicaments Dérivés du Plasma AO 2026-28. By Ted. Awarded to Cf fichier Excel joint (EUR 47.6M).
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in France, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: FrenchThis tender, identified by TED notice 148999-2026, seeks the procurement of plasma-derived medicinal products for the period 2026-2028. The contracting authority, based in France, is issuing this open tender (AO) for supplies of these critical pharmaceuticals. The Common Procurement Vocabulary (CPV) code associated with this procurement is "Plasma extracts." This represents a significant opportunity for manufacturers and suppliers specializing in the production and distribution of a wide range of plasma-derived therapies.
Prospective bidders will likely be expected to demonstrate a robust track record in the pharmaceutical sector, with a particular focus on plasma fractionation and the manufacturing of sterile, high-quality medicinal products. Key requirements will typically include adherence to stringent regulatory standards, such as Good Manufacturing Practices (GMP), and the ability to ensure a consistent and reliable supply chain. Bidders may also need to provide detailed specifications of their product offerings, including proof of efficacy, safety profiles, and compliance with relevant European Medicines Agency (EMA) guidelines. Furthermore, experience in managing large-scale pharmaceutical contracts and providing comprehensive logistical support across France will be a crucial consideration for the contracting authority.
This procurement is vital for ensuring the continued availability of essential plasma-derived treatments within the French healthcare system.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 4, 2026. Last refreshed 13 days ago. Original language: French. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in France. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Cf fichier Excel joint. The award notice is archived on BidsFactory for transparency and market intelligence.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
Cf fichier Excel joint was awarded the contract for €47,609,147. The figure reflects the value disclosed by the contracting authority in the award notice.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Companies That Won Similar
Companies with awards in Health & Medical in France